# Daily Chlorexidine Bath for Health Care Associated Infection Prevention

> **NCT05485051** · PHASE3 · COMPLETED · sponsor: **Hospital do Coracao** · enrollment: 15730 (actual)

## Conditions studied

- Health Care Associated Infection
- Ventilator Associated Pneumonia
- Central Line-associated Bloodstream Infection (CLABSI)
- Catheter-Associated Urinary Tract Infection

## Interventions

- **OTHER:** 2% chlorhexidine digluconate solution with surface-active agents
- **OTHER:** Usual Baths

## Key facts

- **NCT ID:** NCT05485051
- **Lead sponsor:** Hospital do Coracao
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-03
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 15730 (ACTUAL)
- **Last updated:** 2024-06-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05485051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05485051, "Daily Chlorexidine Bath for Health Care Associated Infection Prevention". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05485051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*